FDAers: Strict Conflict Of Interest Policies Impede Ad Comm Work

Examining conflict of interest rules for advisory committee involvement should be a priority for FDA as the agency looks at revamping its process for gathering outside expertise, two agency center heads said Tuesday (June 6). FDA Commissioner Robert Califf has said in recent months that the agency is reviewing its advisory committee processes and it may hold more meetings moving forward, but fewer votes. But FDA’s directors for both biologics and drugs said during a town hall held at the...